Skip to main content


A message from Nestlé Health Science Consumer Services about Alfaré® specialised infant formula which is to be discontinued - 26 June 2023

Alfare® extensively hydrolysed infant formula is being deleted in Australia. 

For current PBS prescription holders, Alfaré® is in stock and should be available until around early November 2023, based on current prescribing. 

Parents and caregivers holding prescriptions for Alfaré® should speak to their healthcare professional about suitable alternatives. 

For more information, contact Nestlé Health Science Consumer Services on 1800 671 628


IMPORTANT NOTICE: Breast milk is best for babies and provides ideal nutrition. Good maternal nutrition is important for the preparation and maintenance of breastfeeding. Introducing partial bottle feeding could negatively affect breastfeeding and reversing a decision not to breastfeed is difficult. Professional advice should be followed on infant feeding. Infant formula should be prepared and used exactly as directed or it could pose a health hazard. The preparation requirements and weekly cost of providing infant formula until 12 months of age should be considered before making a decision to formula feed. Mothers should be encouraged to continue breastfeeding even when their infants have cow’s milk protein allergy. If a decision to use an infant formula for special dietary use is taken, it must be used under medical supervision.

Alfaré® is an infant formula product for special dietary use and must be used under medical supervision. It is not suitable for general use.


If you are having an allergic reaction follow advice on your ASCIA Action Plan.

If in doubt, give the Anapen® or EpiPen®.

Do not call us for emergency advice.

If you do not have an ASCIA Action Plan and/or an Anapen® or EpiPen® call triple zero (000) for an ambulance.